Case Studies

Researchers at Glasgow University have found the key to avoiding Type 2 diabetes.

Results of study backfire on Novartis in head to head study. In a clearly unintended gift, Novartis AG released a study that gave Pfizer Inc. boasting rights for its blood pressure medicine, Norvasc.

For all patients with Type 2 diabetes consideration should now be given to whether they warrant statin therapy .